2.79↑0.00 (0.00%)
04:01 PM,28th Nov 2023BSE : 531686
NSE :
Sector : Health care
ISIN Code : INE537C01019
Last Updated: Nov 28 2023 | 04:01 PM IST
Market Cap (₹ Cr) | 0 |
Turnover (₹ Cr) | 0.00 |
Volume (Shares) | |
Face Value | 10 |
52-WK High | 0.00 |
52-WK High Date | Invalid date |
52-WK Low | 0.00 |
52-WK Low Date | Invalid date |
All Time High | 0.00 |
All Time High Date | Invalid date |
All Time Low | 0.00 |
All Time Low Date | Invalid date |
Advik Laboratories Limited is engaged in the manufacture and sale of pharmaceutical products in India. It offers ethical generic and over the counter drugs in various formulations. The company's generic product portfolio comprises antibacterial; antiallergics; antifungals; analgesic antipyretic and anti-inflammatory; antihypertensives; anthelminthics; antimalarials; corticosteroids; erectile dysfunction; gastrointestinal agents; sedatives; and other miscellaneous products. Advik Laboratories Limited has a technical collaboration with PFC Pharma Focus Ltd. The company is based in New Delhi India. It also markets its products in the Middle East South America and Africa. Advik Laboratories Limited was promoted in the 1994 by Jain along with a group of dedicated professionals. The company commenced commercial production in 1997. In his leadership the company has witnessed a fast growth rate without compromise to quality.During the year 2003-2004 the company established their brand Zin - Ten (an anti- allergic tablets) in the oversea market. During the year 2004-2005 the company launched the new marketing set up and necessary approvals were taken for the new range of product like Majispa Robial Chewfe-C Stibomin Wibatol Wibatol-O Twosum and Arfagel. During the year 2005-2006 the company bagged Govt. supply contracts from Govt. of Andhra Pradesh and Kerala Govt. for supply of Paracetamol. The company executed both the contracts on time.During the year 2007-2008 the company compliance of current guidelines requires good amount of funds for modernization of its plant as per standards of WHO-GMP level.
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 5 |
EPS - TTM (₹) [S] | 0.00 |
P/E Ratio (X) [S] | 2.20 |
Face Value (₹) | 10 |
Latest Dividend (%) | - |
Latest Dividend Date | - |
Dividend Yield (%) | - |
Book Value Share (₹) [S] | 1.27 |
P/B Ratio (₹) [S] | 2.20 |
[*C] Consolidated [*S] Standalone |
Scheme Name ↑↓ | Amount Invested ( ₹ Cr ) ↑↓ | No Of Shares ↑↓ | Net Asset (%) ↑↓ |
---|
Date↑↓ | Broker↑↓ | Action↑↓ | Prices(Rs)↑↓ | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High | 2.79 2.79 |
Week Low/High | 2.79 3.00 |
Month Low/High | 2.66 3.00 |
Year Low/High | 1.91 3.00 |
All time Low/High | 0.32 53.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | % | % | 1.15 | 1.34% |
1 Month | 4.89% | % | 4.16 | 4.84% |
3 Month | % | % | 2.60 | 3.72% |
6 Month | % | % | 6.05 | 7.69% |
1 Year | % | % | 5.83 | 6.98% |
3 Year | % | % | 51.25 | 54.74% |
Managing Director : Peeyush Kumar Aggarwal
Company Sec. & Compli. Officer : Pooja Chuni
Independent Director : Madhu Sharma
Director : Ram Niwas Sharma
Additional Director : Ajay Sharma
Registered Office: 138 Roz-Ka-Meo Industrial Area, Sohna,Mewat,Haryana-122103 Ph: 91-124-2362471/2014471
Email:mail@advikindia.com